InspireMD receives European approval to resume MGuard Prime manufacturing

InspireMD announced that it received European regulatory approval to resume the manufacturing of its MGuard Prime EPS stent with a modified stent securement process . The company also received approval to modify and re-deploy existing MGuard Prime EPS stents that have been returned by clinical and commercial sites worldwide. The European regulatory approval follows a Voluntary Field Action (VFA) InspireMD implemented on April 30.

View Comments (0)